A detailed history of Norges Bank transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Norges Bank holds 991,051 shares of TXG stock, worth $16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
991,051
Holding current value
$16 Million
% of portfolio
0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$19.45 - $37.37 $19.3 Million - $37 Million
991,051 New
991,051 $19.3 Million
Q4 2023

Feb 09, 2024

BUY
$34.32 - $57.55 $22.2 Million - $37.3 Million
647,996 New
647,996 $36.3 Million
Q3 2023

Nov 13, 2023

SELL
$40.86 - $62.98 $33.1 Million - $51 Million
-809,335 Closed
0 $0
Q2 2023

Aug 14, 2024

SELL
$50.96 - $58.72 $20.9 Million - $24.1 Million
-410,507 Reduced 41.42%
580,544 $32.4 Million
Q2 2023

Aug 14, 2023

SELL
$50.96 - $58.72 $36.8 Million - $42.4 Million
-721,629 Closed
0 $0
Q1 2023

May 15, 2024

BUY
$35.33 - $55.79 $26.7 Million - $42.2 Million
756,640 New
756,640 $42.2 Million
Q4 2022

Feb 14, 2023

BUY
$24.4 - $41.3 $21.8 Million - $37 Million
895,047 New
895,047 $32.6 Million
Q3 2022

Nov 13, 2023

BUY
$28.48 - $52.59 $23 Million - $42.6 Million
809,335 New
809,335 $23 Million
Q2 2022

Aug 14, 2023

BUY
$36.95 - $82.41 $26.7 Million - $59.5 Million
721,629 New
721,629 $32.7 Million
Q1 2022

May 12, 2023

SELL
$55.7 - $145.79 $9.92 Million - $26 Million
-178,179 Reduced 19.91%
716,868 $54.5 Million
Q1 2022

May 09, 2022

SELL
$55.7 - $145.79 $41 Million - $107 Million
-735,751 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$135.05 - $182.59 $99.4 Million - $134 Million
735,751 New
735,751 $110 Million
Q3 2021

Nov 14, 2022

BUY
$145.58 - $192.14 $109 Million - $143 Million
745,406 New
745,406 $109 Million
Q3 2021

Nov 05, 2021

SELL
$145.58 - $192.14 $96.5 Million - $127 Million
-662,693 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$134.22 - $202.37 $88.9 Million - $134 Million
662,693 New
662,693 $130 Million
Q2 2021

Aug 10, 2021

SELL
$134.22 - $202.37 $58.1 Million - $87.6 Million
-432,847 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$140.25 - $196.86 $60.7 Million - $85.2 Million
432,847 New
432,847 $78.3 Million
Q4 2020

Feb 10, 2021

SELL
$126.47 - $163.7 $2.53 Million - $3.27 Million
-20,000 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$87.44 - $125.0 $1.75 Million - $2.5 Million
20,000 New
20,000 $2.49 Million
Q3 2020

Nov 10, 2020

SELL
$87.44 - $125.0 $1.75 Million - $2.5 Million
-20,000 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$58.39 - $89.31 $1.17 Million - $1.79 Million
20,000 New
20,000 $1.79 Million
Q2 2020

Aug 07, 2020

SELL
$58.39 - $89.31 $1.17 Million - $1.79 Million
-20,000 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$51.57 - $106.62 $1.03 Million - $2.13 Million
20,000 New
20,000 $1.25 Million
Q1 2020

May 08, 2020

SELL
$51.57 - $106.62 $1.03 Million - $2.13 Million
-20,000 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$46.07 - $79.54 $921,400 - $1.59 Million
20,000 New
20,000 $1.53 Million
Q4 2019

Feb 12, 2020

SELL
$46.07 - $79.54 $921,400 - $1.59 Million
-20,000 Closed
0 $0
Q3 2019

Nov 13, 2020

BUY
$49.99 - $62.0 $999,800 - $1.24 Million
20,000 New
20,000 $1.01 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.54B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.